0001615774-18-001625.txt : 20180306
0001615774-18-001625.hdr.sgml : 20180306
20180306130846
ACCESSION NUMBER: 0001615774-18-001625
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180212
FILED AS OF DATE: 20180306
DATE AS OF CHANGE: 20180306
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Brennan Peter F
CENTRAL INDEX KEY: 0001501353
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-08696
FILM NUMBER: 18669283
MAIL ADDRESS:
STREET 1: 1375 KINGS HIGHWAY EAST
CITY: FAIRFIELD
STATE: CT
ZIP: 06824
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CALMARE THERAPEUTICS Inc
CENTRAL INDEX KEY: 0000102198
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 362664428
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1375 KINGS HIGHWAY EAST
CITY: FAIRFIELD
STATE: CT
ZIP: 06824
BUSINESS PHONE: (203) 368-6044
MAIL ADDRESS:
STREET 1: 1375 KINGS HIGHWAY EAST
CITY: FAIRFIELD
STATE: CT
ZIP: 06824
FORMER COMPANY:
FORMER CONFORMED NAME: COMPETITIVE TECHNOLOGIES INC
DATE OF NAME CHANGE: 19941227
FORMER COMPANY:
FORMER CONFORMED NAME: UNIVERSITY PATENTS INC
DATE OF NAME CHANGE: 19920703
4
1
s109137_form4.xml
4
X0306
4
2018-02-12
0
0000102198
CALMARE THERAPEUTICS Inc
CTTC
0001501353
Brennan Peter F
1375 KINGS HIGHWAY EAST
FAIRFIELD
CT
06824
1
0
0
0
Common Stock
2018-02-12
4
M
0
4594117
A
13850181
D
Warrant
0.6
2018-02-12
4
C
0
123530
0.6
A
Common Stock
123530
123530
D
Warrant
0.6
2018-02-12
4
C
0
411765
0.6
A
Common Stock
411765
535295
D
Warrant
0.13
2018-02-12
4
C
0
764706
0.13
A
Common Stock
764706
1300001
D
Warrant
0.13
2018-02-12
4
C
0
1882362
0.13
A
Common Stock
1882362
3182353
D
Warrant
0.125
2018-02-12
4
C
0
1411765
0.125
A
Common Stock
1411765
4594117
D
The Reporting Person received a warrant to purchase 123,530 shares of Common Stock on 02/23/2017 inconnection with a Note Purchase Agreement executed on that date. The exercise price was $0.60 per share. The warrant was exercisable immediately and expired in one year-02/23/2018.
The Reporting Person received a warrant to purchase 411,765 shares of Common Stock on 05/16/2017 in connection with a Note Purchase Agreement executed on that date. The exercise price was $0.60 per share. The warrant was exercisable immediately and expired in one year-05/16/2018.
The Reporting Person received a warrant to purchase 764,706 shares of Common Stock on 07/24/2017 in connection with a Note Purchase Agreement executed on that date. The exercise price was $0.13 per share. The warrant was exercisable immediately and expired in one year - 07/24/2018.
The Reporting Person received a warrant to purchase 1,882,352 shares of Common Stock on 12/29/2017 in connection with a Note Purchase Agreement executed on that date. The exercise price was $0.13 per share. The warrant was exercisable immediately and expired in one year-12/29/2018.
The Reporting Person received a warrant to purchase 1,411,765 shares of Common Stock on 02/01/2018 in connection with a Note Purchase Agreement executed on that date. The exercise price was $0.125 per share. The warrant was exercisable immediately and expired in one year- 02/01/2019.
/s/ Peter Brennan
2018-03-06